| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | KIRSKE DAVID Chief Financial Officer | Sale | -16,961 | -8.78%176,293 | $4.29 | $72,820 | View SEC filing | |
| 2025-10-27 | Craig Adam R Executive Chairman | Purchase | +86,206 | +29.74%376,087 | $2.90 | $249,997 | View SEC filing | |
| 2025-05-20 | Baldry Mark Chief Commercial Officer | Purchase | +1,032 | +4.25%25,337 | $2.48 | $2,561 | View SEC filing | |
| 2025-02-14 | Baldry Mark Chief Commercial Officer | Purchase | +35,050 | +37.24%129,173 | $0.55 | $19,252 | View SEC filing | |
| 2025-01-27 | Ragan Paula President and CEO | Sale | -76,473 | -6.57%1,087,386 | $0.45 | $34,719 | View SEC filing | |
| 2025-01-27 | Mostafa Adam S. Chief Financial Officer | Sale | -74,773 | -100.00%0 | $0.45 | $33,947 | View SEC filing | |
| 2025-01-27 | Baldry Mark Chief Commercial Officer | Sale | -29,159 | -23.65%94,123 | $0.45 | $13,241 | View SEC filing | |
| 2025-01-27 | DiBiase Mary Chief Operating Officer | Sale | -22,258 | -4.34%490,980 | $0.45 | $10,094 | View SEC filing | |
| 2025-01-27 | Arbet-Engels Christophe Chief Medical Officer | Sale | -11,624 | -45.00%14,207 | $0.45 | $5,284 | View SEC filing | |
| 2024-11-19 | Ragan Paula President and CEO | Sale | -31,897 | -3.11%993,919 | $0.39 | $12,583 | View SEC filing | |
| 2024-10-16 | Ragan Paula President and CEO | Sale | -31,897 | -3.02%1,025,816 | $0.56 | $17,926 | View SEC filing | |
| 2024-10-08 | Mostafa Adam S. Chief Financial Officer | Sale | -230,645 | -100.00%0 | $0.55 | $126,901 | View SEC filing | |
| 2024-10-08 | Baldry Mark Chief Commercial Officer | Sale | -11,127 | -18.66%48,509 | $0.58 | $6,506 | View SEC filing | |
| 2024-10-08 | Ragan Paula President and CEO | Sale | -239,436 | -18.46%1,057,713 | $0.55 | $131,522 | View SEC filing | |
| 2024-10-08 | DiBiase Mary Chief Operating Officer | Sale | -67,695 | -13.02%452,060 | $0.57 | $38,329 | View SEC filing | |
| 2024-10-08 | Taveras Arthur Chief Scientific Officer | Sale | -76,920 | -16.54%388,026 | $0.56 | $43,306 | View SEC filing | |
| 2024-09-11 | DiBiase Mary Chief Operating Officer | Sale | -2,642 | -0.91%289,110 | $0.66 | $1,738 | View SEC filing | |
| 2024-03-11 | Taveras Arthur Chief Scientific Officer | Sale | -14,235 | -5.73%234,301 | $0.88 | $12,552 | View SEC filing | |
| 2024-03-11 | Ragan Paula President and CEO | Sale | -49,678 | -6.10%765,068 | $0.88 | $43,856 | View SEC filing | |
| 2024-03-11 | Mostafa Adam S. Chief Financial Officer | Sale | -52,500 | -100.00%0 | $0.88 | $46,347 | View SEC filing | |
| 2024-03-11 | DiBiase Mary Chief Operating Officer | Sale | -15,409 | -5.02%291,752 | $0.88 | $13,591 | View SEC filing | |
| 2024-02-12 | DiBiase Mary Chief Operating Officer | Sale | -3,683 | -1.18%307,161 | $1.01 | $3,709 | View SEC filing | |
| 2024-02-12 | Taveras Arthur Chief Scientific Officer | Sale | -787 | -0.32%248,536 | $1.01 | $793 | View SEC filing | |
| 2024-02-12 | Ragan Paula President and CEO | Sale | -21,695 | -2.59%814,746 | $1.01 | $21,892 | View SEC filing | |
| 2024-02-12 | Mostafa Adam S. Chief Financial Officer | Sale | -27,721 | -34.56%52,500 | $1.01 | $27,973 | View SEC filing |
1-25 of 110
